SEC 13F Intelligence

Rtw Investments, LP / MDGL

Rtw Investments, LP’s Madrigal Pharmaceuticals Inc Position

Does Rtw Investments, LP own Madrigal Pharmaceuticals Inc (MDGL)? Yes1.99M shares worth $1.0B (+10.38% of its 13F portfolio) as of Q1 2026.

Position Value
$1.0B
Q1 2026
Shares
1.99M
% of Portfolio
+10.38%
Quarters Held
12
currently held

Position History MDGL

Reported value by quarter
Q2 ’23: $51MQ2 ’23Q3 ’23: $45MQ4 ’23: $189MQ4 ’23Q1 ’24: $106MQ2 ’24: $537MQ2 ’24Q3 ’24: $423MQ4 ’24: $615MQ4 ’24Q1 ’25: $660MQ2 ’25: $603MQ2 ’25Q3 ’25: $914MQ4 ’25: $1.2BQ4 ’25Q1 ’26: $1.0Bfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.99M$1.0B+10.38%
Q4 20251.99M$1.2B+11.63%
Q3 20251.99M$914M+11.27%
Q2 20251.99M$603M+8.59%
Q1 20251.99M$660M+10.10%
Q4 20241.99M$615M+9.30%
Q3 20241.99M$423M+6.12%
Q2 20241.92M$537M+8.31%
Q1 2024397.0K$106M+1.57%
Q4 2023815.2K$189M+2.95%
Q3 2023309.5K$45M+0.95%
Q2 2023221.6K$51M+0.97%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rtw Investments, LP’s full portfolio or all institutional holders of MDGL.